378 related articles for article (PubMed ID: 27497989)
1. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption.
Sims NA
Int J Biochem Cell Biol; 2016 Oct; 79():14-23. PubMed ID: 27497989
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts.
Sims NA; Vrahnas C
Arch Biochem Biophys; 2014 Nov; 561():22-8. PubMed ID: 24875146
[TBL] [Abstract][Full Text] [Related]
3. Talking among ourselves: paracrine control of bone formation within the osteoblast lineage.
Tonna S; Sims NA
Calcif Tissue Int; 2014 Jan; 94(1):35-45. PubMed ID: 23695526
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
[TBL] [Abstract][Full Text] [Related]
5. Influences of the IL-6 cytokine family on bone structure and function.
Sims NA
Cytokine; 2021 Oct; 146():155655. PubMed ID: 34332274
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
[TBL] [Abstract][Full Text] [Related]
7. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
[TBL] [Abstract][Full Text] [Related]
8. Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte-Derived Parathyroid Hormone-Related Protein.
Ansari N; Ho PW; Crimeen-Irwin B; Poulton IJ; Brunt AR; Forwood MR; Divieti Pajevic P; Gooi JH; Martin TJ; Sims NA
J Bone Miner Res; 2018 Jan; 33(1):137-153. PubMed ID: 28914969
[TBL] [Abstract][Full Text] [Related]
9. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling.
Guihard P; Danger Y; Brounais B; David E; Brion R; Delecrin J; Richards CD; Chevalier S; Rédini F; Heymann D; Gascan H; Blanchard F
Stem Cells; 2012 Apr; 30(4):762-72. PubMed ID: 22267310
[TBL] [Abstract][Full Text] [Related]
10. The cytokine interleukin-11 crucially links bone formation, remodeling and resorption.
Kespohl B; Schumertl T; Bertrand J; Lokau J; Garbers C
Cytokine Growth Factor Rev; 2021 Aug; 60():18-27. PubMed ID: 33940443
[TBL] [Abstract][Full Text] [Related]
11. The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation.
Johnson RW; Brennan HJ; Vrahnas C; Poulton IJ; McGregor NE; Standal T; Walker EC; Koh TT; Nguyen H; Walsh NC; Forwood MR; Martin TJ; Sims NA
J Bone Miner Res; 2014 Jun; 29(6):1492-505. PubMed ID: 24339143
[TBL] [Abstract][Full Text] [Related]
12. Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease.
Sims NA; Quinn JM
Bonekey Rep; 2014; 3():527. PubMed ID: 24876928
[TBL] [Abstract][Full Text] [Related]
13. Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation.
Johnson RW; White JD; Walker EC; Martin TJ; Sims NA
Bone; 2014 Jul; 64():47-56. PubMed ID: 24721701
[TBL] [Abstract][Full Text] [Related]
14. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
15. IL-6 exhibits both
McGregor NE; Murat M; Elango J; Poulton IJ; Walker EC; Crimeen-Irwin B; Ho PWM; Gooi JH; Martin TJ; Sims NA
J Biol Chem; 2019 May; 294(19):7850-7863. PubMed ID: 30923130
[TBL] [Abstract][Full Text] [Related]
16. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
17. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
18. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms in coupling of bone formation to resorption.
Martin T; Gooi JH; Sims NA
Crit Rev Eukaryot Gene Expr; 2009; 19(1):73-88. PubMed ID: 19191758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
